[{"data":1,"prerenderedAt":20},["ShallowReactive",2],{"recruit-6bdc73f469ea372c0050e06f0a413ee2":3},{"_id":4,"slug":4,"title":5,"indication":6,"enrollment_target":7,"enrollment_now":8,"deadline":9,"sponsor":10,"hospital":11,"department":12,"trial_phase":13,"enrollment_status_text":14,"cover":15,"intro":16,"inclusion":17,"exclusion":18,"process":19,"contact":6},"6bdc73f469ea372c0050e06f0a413ee2","NK细胞应用结直肠癌肝转移临床试验","",35,0,"2027-06-30","先康达生物","博鳌超级医院","肝胆外科/肿瘤科","I/II期临床","已结束","https://6875-huali-cell-8geyb3yje6a285d1-1419749029.tcb.qcloud.la/assets/covers/cover-05.jpg","评价高活性NK细胞输注联合化疗治疗结直肠癌肝转移的安全性、耐受性和客观缓解率。",[],[],[],1779368115445]